spacer
home > epc > spring 2009 > ediary time
PUBLICATIONS
European Pharmaceutical Contractor

eDiary Time

Back in the days of pen and paper clinical trials monitoring, something familiar but disconcerting caught my attention as I got out of the car. There in the next car sat a patient busy filling in his diary card with peak expiratory flow (PEF) readings and symptoms for the past month. Mentioning this to the investigating consultant, he called the patient in, commended him for having a complete diary, and then as he rubbed his finger over it, said, “oh dear the ink is still wet!” Having observed this, I concluded that there had to be a better way of recording diary data. The answer came in the early 1990s with the development of e-spirometric diaries. Chowienczyk et al compared paper versus electronic recording of spirometry data, demonstrating that 33 per cent of completed entries were either invented, mistimed or misread, and were often retrospectively entered (1). Since then, other studies have confirmed that paper diaries often contain invented data (2,3).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Initially qualifying as an entomologist, Aleck Harrison swiftly moved from ‘bugs to drugs’ and spent 34 years with Boehringer Ingelheim Ltd. Evolving from CRA to managing international respiratory studies, he advised a number of companies on spirometric diary development. Having semiretired, he started the consultancy of AJH Partners (Contract Research and Consultancy). Amongst his recent activities, he has supported respiratory companies, including Vitalograph Ltd, with the introduction and development of their centralised spirometry system.

spacer
Aleck Harrison
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement